Novartis

If you’ve ever wondered how new Multiple Sclerosis drugs are developed, evaluated, and finally approved for the market, Bloomberg.com offers a link to the video of the FDA Committee Meeting on Novartis’s new Gilenia, the first pill for Multiple Sclerosis. After drug testing and before the FDA approves a new medication, a panel of health […]

Continue reading about Gilenia, MS Pill, Recommended for Approval by Panel

css.php